What is Mbody AI Ltd's earnings per share (EPS)?

Mbody AI Ltd (MBAI) reported diluted earnings per share of $0.66 for fiscal year 2025. This represents a 115.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Mbody AI Ltd (MBAI) Financials

MBAI

FY2025 annual

Revenue Not reported for FY2025

Net Income $4.1M YoY not available

EPS (Diluted) $0.66 +115.3% YoY

Operating Cash Flow -$46K YoY not available

Market Cap $8.9M as of Sep 3, 2026

Price / Sales n/m no revenue reported

Price / Earnings 2.2x on $4.1M net income, FY2025

Price / Book 2.6x on $3.4M equity, Q4 FY2025

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 3, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period FY2025, ended Dec 31, 2025 Reported Apr 27, 2026 Currency USD FYE December

Newest figures come from the 10-K for FY2025, filed Apr 27, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the MBAI SEC filings page.

This page shows Mbody AI Ltd (MBAI) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 13 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Financial health score not available

Mbody AI Ltd does not currently provide enough eligible data for a peer-relative financial health score, so none is published. The signals and metrics below are current.

Piotroski F-Score Partial

1/5

Mbody AI Ltd passes 1 of 5 computable financial strength tests (4 of the nine could not be computed from available data). 1 of 3 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution).

Earnings Quality No Cash Backing

$0.01used

For every $1 of reported earnings, Mbody AI Ltd used $0.01 of operating cash (-$46K OCF vs $4.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Key Financial Metrics

Export CSV

Earnings & Revenue

None of these metrics is reported for Q4 2025.

Cash & Balance Sheet

Cash & Debt

$2K

YoY-99.2%

QoQ-99.8%

Mbody AI Ltd held $2K in cash as of Q4 2025; long-term debt is not reported for that period.

Shares Outstanding

YoY+20.0%

QoQ+20.0%

Mbody AI Ltd had 7M shares outstanding in Q4 2025. This represents an increase of 20.0% from the same quarter a year earlier. Against the prior quarter it is up 20.0%.

Free Cash Flow

Not reported for Q4 2025.

Dividends Per Share

Not reported for Q4 2025.

Margins & Returns

None of these metrics is reported for Q4 2025.

Capital Allocation

None of these metrics is reported for Q4 2025.

MBAI Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MBAI quarterly income statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
R&D Expenses	N/A	N/A	$8.3M-41.8%	$14.3M+15.6%	$12.3M+23.4%	$10.0M-4.4%	$10.5M+37.5%	$7.6M+11.4%	$6.8M+24.5%	$5.5M-5.9%	$5.8M+106.1%	$2.8M-2.1%	$2.9M
SG&A Expenses	$2.4M	N/A	$9.6M+65.7%	$5.8M+15.9%	$5.0M+26.7%	$3.9M+9.2%	$3.6M+4.4%	$3.4M+8.9%	$3.2M-11.4%	$3.6M-46.1%	$6.6M+289.1%	$1.7M+56.2%	$1.1M
Operating Income	-$2.4M	N/A	-$19.3M+3.7%	-$20.0M-15.7%	-$17.3M-24.3%	-$13.9M+1.0%	-$14.1M-27.2%	-$11.1M-10.6%	-$10.0M-10.4%	-$9.1M+27.3%	-$12.5M-174.8%	-$4.5M-14.2%	-$4.0M
EBITDA	-$2.4M	N/A	-$19.1M+2.8%	-$19.6M-14.7%	-$17.1M-24.2%	-$13.8M+1.2%	-$14.0M-27.8%	-$10.9M-10.9%	-$9.8M-10.2%	-$8.9M+27.8%	-$12.4M-177.6%	-$4.5M-14.4%	-$3.9M
Interest Expense	N/A	N/A	$13K+8.3%	$12K-7.7%	$13K+8.3%	$12K+50.0%	$8K+14.3%	$7K0.0%	$7K0.0%	$7K-85.1%	$47K+683.3%	$6K+20.0%	$5K
Income Tax	N/A	N/A	N/A	N/A	N/A	N/A	N/A	-$1K-116.7%	$6K-25.0%	$8K	N/A	N/A	N/A
Net Income	$4.1M	N/A	-$17.6M+8.1%	-$19.1M-11.1%	-$17.2M-24.2%	-$13.8M-0.1%	-$13.8M-30.7%	-$10.6M-8.4%	-$9.8M-10.7%	-$8.8M+28.2%	-$12.3M-1914.8%	-$610K+81.9%	-$3.4M
EPS (Basic)	$0.66+115.3%	-$4.30-43.3%	-$3.00-189.0%	$3.37-18.6%	$4.14-54.1%	$9.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	$0.66+115.3%	-$4.30-43.3%	-$3.00-189.0%	$3.37	$4.14	$9.01	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	6M+6.6%	6M0.0%	6M+3.1%	6M	4M	2M	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
R&D Expenses	N/A	N/A	N/A	N/A	N/A	$4.5M+26.4%	N/A	N/A
SG&A Expenses	N/A	N/A	N/A	N/A	N/A	$1.6M+17.9%	N/A	N/A
Operating Income	N/A	N/A	N/A	N/A	N/A	-$7.4M-51.9%	N/A	N/A
Net Income	N/A	N/A	N/A	N/A	N/A	-$6.9M-43.1%	-$4.4M+23.9%	N/A
EPS (Basic)	N/A	N/A	N/A	N/A	N/A	$1.18+43.9%	N/A	N/A
EPS (Diluted)	N/A	N/A	N/A	N/A	N/A	$1.18	N/A	N/A
Diluted Shares (Avg)	N/A	N/A	N/A	N/A	N/A	6M	N/A	N/A

Not reported in any period shown, so not listed: Revenue, Cost of Revenue, Gross Profit, EBITDA, Interest Expense, Income Tax.

MBAI Balance Sheet

MBAI quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Total Assets	$7.5M+1885.7%	$377K-98.5%	$25.0M-44.9%	$45.4M-18.4%	$55.7M+183.4%	$19.6M+108.3%	$9.4M-38.9%	$15.4M+95.2%	$7.9M-35.7%	$12.3M-19.6%	$15.3M+412.5%	$3.0M	N/A
Current Assets	$219K-17.4%	$265K-98.9%	$24.9M-41.7%	$42.6M-19.2%	$52.8M+186.4%	$18.4M+118.3%	$8.4M-43.7%	$15.0M+102.4%	$7.4M-37.7%	$11.9M-20.4%	$14.9M+1105.9%	$1.2M	N/A
Cash & Equivalents	$2K-99.2%	$265K-97.0%	$8.8M+116.2%	$4.1M-84.5%	$26.5M+243.5%	$7.7M+0.2%	$7.7M-10.3%	$8.6M+22.5%	$7.0M-39.9%	$11.6M+23.9%	$9.4M+773.7%	$1.1M-78.4%	$5.0M
Short-Term Investments	$217K	$0-100.0%	$15.9M-57.7%	$37.6M+49.8%	$25.1M+149.1%	$10.1M	$0-100.0%	$5.6M	$0	$0-100.0%	$4.8M	$0	$0
Long-Term Investments	$6.5M	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$4.0M+121.6%	$1.8M+37.4%	$1.3M-67.8%	$4.1M-16.9%	$5.0M+52.4%	$3.3M+2.0%	$3.2M+32.8%	$2.4M+20.2%	$2.0M+6.0%	$1.9M-28.8%	$2.6M-30.5%	$3.8M	N/A
Current Liabilities	$4.0M+123.6%	$1.8M+36.2%	$1.3M-61.0%	$3.4M-15.7%	$4.0M+35.6%	$3.0M+6.4%	$2.8M+26.2%	$2.2M+42.2%	$1.6M+14.3%	$1.4M-34.1%	$2.1M-27.5%	$2.9M	N/A
Non-Current Liabilities	$0-100.0%	$16K	$0-100.0%	$721K-22.2%	$927K+232.3%	$279K-29.0%	$393K+112.4%	$185K-57.9%	$439K-15.7%	$521K-9.7%	$577K-39.3%	$951K	N/A
Total Equity	$3.4M+337.0%	-$1.4M-106.1%	$23.7M-42.7%	$41.3M-18.5%	$50.7M+209.5%	$16.4M+162.7%	$6.2M-52.2%	$13.0M+120.7%	$5.9M-43.3%	$10.4M-17.7%	$12.6M+1631.2%	-$826K-56.4%	-$528K
Retained Earnings	-$165.9M+2.4%	-$170.0M-17.4%	-$144.9M-13.8%	-$127.3M-17.7%	-$108.2M-18.9%	-$91.0M-17.9%	-$77.1M-21.9%	-$63.3M-20.1%	-$52.7M-22.8%	-$42.9M-25.9%	-$34.1M-56.3%	-$21.8M	N/A

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Total Assets	$7.5M+1885.7%	$5.8M-68.1%	$377K-98.5%	$18.1M-46.4%	$25.0M-44.9%	$33.7M-37.7%	N/A	$45.4M-18.4%
Current Assets	$219K-17.4%	$1.4M-92.1%	$265K-98.9%	$18.0M-46.0%	$24.9M-41.7%	$33.3M-35.0%	N/A	$42.6M-19.2%
Cash & Equivalents	$2K-99.2%	$1.2M-93.5%	$265K-97.0%	$17.8M+690.8%	$8.8M+116.2%	$2.3M-80.6%	N/A	$4.1M-84.5%
Short-Term Investments	$217K	$0	$0-100.0%	$0-100.0%	$15.9M-57.7%	$29.8M-22.0%	N/A	$37.6M+49.8%
Long-Term Investments	$6.5M	$4.3M	$0	$0	$0	$0	N/A	$0
Total Liabilities	$4.0M+121.6%	$2.0M+119.2%	$1.8M+37.4%	$913K-74.2%	$1.3M-67.8%	$3.5M-24.8%	N/A	$4.1M-16.9%
Current Liabilities	$4.0M+123.6%	$2.0M+117.4%	$1.8M+36.2%	$913K-74.2%	$1.3M-61.0%	$3.5M-10.0%	N/A	$3.4M-15.7%
Non-Current Liabilities	$0-100.0%	$16K	$16K	$0	$0-100.0%	$0-100.0%	N/A	$721K-22.2%
Total Equity	$3.4M+337.0%	$3.8M-78.1%	-$1.4M-106.1%	$17.2M-43.1%	$23.7M-42.7%	$30.2M-38.9%	$37.0M-31.4%	$41.3M-18.5%
Retained Earnings	-$165.9M+2.4%	-$164.8M-9.0%	-$170.0M-17.4%	-$151.2M-9.1%	-$144.9M-13.8%	-$138.6M-16.7%	N/A	-$127.3M-17.7%

Not reported in any period shown, so not listed: Inventory, Accounts Receivable, Goodwill, Long-Term Debt.

MBAI Cash Flow Statement

MBAI quarterly cash flow statement

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Operating Cash Flow	-$46K	N/A	-$17.0M+9.4%	-$18.7M-15.0%	-$16.3M-24.0%	-$13.1M-2.1%	-$12.8M-27.0%	-$10.1M-12.6%	-$9.0M-13.4%	-$7.9M+8.2%	-$8.6M-123.8%	-$3.9M-28.1%	-$3.0M
Depreciation & Amortization	$0-100.0%	$161K-24.1%	$212K-47.5%	$404K+97.1%	$205K+38.5%	$148K+28.7%	$115K-21.8%	$147K-6.4%	$157K+20.8%	$130K+41.3%	$92K+17.9%	$78K+1.3%	$77K
Stock-Based Compensation	-$12K-200.0%	$12K+121.1%	-$57K-106.5%	$879K+79.0%	$491K+20.3%	$408K-20.9%	$516K+893.8%	-$65K-109.0%	$726K-40.0%	$1.2M-67.5%	$3.7M+1093.6%	$312K+457.1%	$56K
Capital Expenditures	N/A	N/A	$83K-82.9%	$486K-51.7%	$1.0M+165.4%	$379K+126.9%	$167K+77.7%	$94K-59.3%	$231K+39.2%	$166K-38.5%	$270K+487.0%	$46K+2.2%	$45K
Free Cash Flow	N/A	N/A	-$17.0M+11.2%	-$19.2M-11.1%	-$17.3M-28.0%	-$13.5M-3.7%	-$13.0M-27.4%	-$10.2M-10.8%	-$9.2M-13.9%	-$8.1M+9.1%	-$8.9M-128.1%	-$3.9M-27.7%	-$3.1M
Investing Cash Flow	$48K+105.7%	-$840K-103.9%	$21.4M+270.7%	-$12.5M+21.9%	-$16.0M-53.2%	-$10.5M-291.9%	$5.4M+195.1%	-$5.7M-2377.5%	-$231K-105.0%	$4.6M+191.6%	-$5.1M	N/A	N/A
Financing Cash Flow	N/A	N/A	N/A	$8.8M-82.7%	$51.0M+116.4%	$23.6M+262.2%	$6.5M-63.3%	$17.8M+288.2%	$4.6M-15.7%	$5.4M-75.4%	$22.0M	N/A	N/A

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-K

Not reported in any period shown, so not listed: Operating Cash Flow, Depreciation & Amortization, Stock-Based Compensation, Capital Expenditures, Free Cash Flow, Investing Cash Flow, Financing Cash Flow, Dividends Paid, Share Buybacks.

MBAI Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

MBAI quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K
Return on Equity	120.4%	N/A	-74.2%-27.9pp	-46.3%-12.3pp	-33.9%+50.6pp	-84.5%+137.4pp	-221.9%-140.7pp	-81.3%+84.2pp	-165.5%-80.7pp	-84.8%+12.4pp	-97.2%	N/A	N/A
Return on Assets	55.3%	N/A	-70.2%-28.2pp	-42.0%-11.1pp	-30.9%+39.6pp	-70.5%+76.2pp	-146.7%-78.1pp	-68.6%+55.0pp	-123.6%-51.8pp	-71.8%+8.6pp	-80.3%-59.9pp	-20.4%	N/A
Current Ratio	0.05-0.1x	0.15-18.5x	18.69+6.2x	12.51-0.5x	13.05+6.9x	6.18+3.2x	3.01-3.7x	6.75+2.0x	4.74-4.0x	8.69+1.5x	7.20+6.8x	0.43	N/A
Debt-to-Equity	1.18	N/A	0.060.0x	0.100.0x	0.10-0.1x	0.20-0.3x	0.51+0.3x	0.18-0.2x	0.34+0.2x	0.180.0x	0.21	N/A	N/A

Metric	Q4'2510-K	Q2'2510-Q	Q4'2410-K	Q2'2410-Q	Q4'2310-K	Q2'2310-Q	Q1'2310-Q	Q4'2210-K
Return on Equity	N/A	N/A	N/A	N/A	N/A	-22.8%-13.1pp	-12.0%-1.2pp	N/A
Return on Assets	N/A	N/A	N/A	N/A	N/A	-20.4%-11.5pp	N/A	N/A
Current Ratio	0.05-0.1x	0.71-19.0x	0.15-18.5x	19.66+10.3x	18.69+6.2x	9.41-3.6x	N/A	12.51-0.5x
Debt-to-Equity	1.18	0.53+0.5x	N/A	0.05-0.1x	0.060.0x	0.120.0x	N/A	0.100.0x

Not reported in any period shown, so not listed: Gross Margin, Operating Margin, Net Margin, Asset Turnover, FCF Margin.

Note: The current ratio is below 1.0 (0.05), indicating current liabilities exceed current assets, which may suggest potential short-term liquidity concerns.

Where Mbody AI Ltd Ranks

Frequently Asked Questions

Is Mbody AI Ltd profitable?

Yes, Mbody AI Ltd (MBAI) reported a net income of $4.1M in fiscal year 2025.

What is Mbody AI Ltd's EBITDA?

Mbody AI Ltd (MBAI) had EBITDA of -$2.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Mbody AI Ltd's return on equity (ROE)?

Mbody AI Ltd (MBAI) has a return on equity of 120.4% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Mbody AI Ltd's operating cash flow?

Mbody AI Ltd (MBAI) recorded an outflow of $46K in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Mbody AI Ltd's total assets?

Mbody AI Ltd (MBAI) had $7.5M in total assets as of fiscal year 2025, including both current and long-term assets.

How many shares does Mbody AI Ltd have outstanding?

Mbody AI Ltd (MBAI) had 7M shares outstanding as of fiscal year 2025.

What is Mbody AI Ltd's current ratio?

Mbody AI Ltd (MBAI) had a current ratio of 0.05 as of fiscal year 2025, which is below 1.0, which may suggest potential liquidity concerns.

What is Mbody AI Ltd's debt-to-equity ratio?

Mbody AI Ltd (MBAI) had a debt-to-equity ratio of 1.18 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Mbody AI Ltd's return on assets (ROA)?

Mbody AI Ltd (MBAI) had a return on assets of 55.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Mbody AI Ltd's P/E ratio?

Mbody AI Ltd (MBAI) trades at 2.2x earnings, its market capitalization divided by net income of $4.1M net income, FY2025. The market capitalization is $8.9M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Mbody AI Ltd's price-to-sales ratio?

Mbody AI Ltd (MBAI) has no price-to-sales ratio at the moment: no revenue reported. The market capitalization is $8.9M as of Sep 3, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Mbody AI Ltd's Piotroski F-Score?

Mbody AI Ltd (MBAI) has a Piotroski F-Score of 1 out of 5 computable signals; 4 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Mbody AI Ltd's earnings high quality?

For every $1 of reported earnings, Mbody AI Ltd (MBAI) used $0.01 of operating cash (-$46K OCF vs $4.1M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.